GU Cancers 2020 | UC breakthroughs: personalized therapy and immunotherapies

VJOncology is committed to improving our service to you

Thomas Powles

Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, gives his thoughts on some of the biggest breakthroughs in urothelial cancer (UC). Specifically discussed is personalized therapy, immunotherapy and the evolving role of PD-L1 testing in metastatic urothelial carcinoma. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter